Pregnancy, Childbirth, and HIVNews

World Health Organization Updates Guidance on Dolutegravir After Reassuring Data Regarding Safety in Early Pregnancy

Fernanda Fernandes Fonseca and Meg Doherty at an IAS 2019 press conference
Fernanda Fernandes Fonseca, M.D. (left), and Meg Doherty, M.D., Ph.D., M.P.H., at an IAS 2019 press conference to discuss dolutegravir safety in pregnancy.Kenyon Farrow
    Sony Salzman

    Sony Salzman


    Sony Salzman is a freelance journalist reporting on health care and medicine, who has won awards in both narrative writing and radio journalism.